bioaccess®

bioaccess® is a specialized contract research organization (CRO) and market access consultancy purpose-built for medtech, biopharma, and radiopharma startups. The company focuses on accelerating first-in-human (FIH) and early-feasibility clinical trials by leveraging the regulatory and cost efficiencies of the Latin American market, particularly in Colombia, Mexico, and Brazil. Headquartered in the US with a robust operational presence across South America, bioaccess® provides end-to-end services including site selection, regulatory dossier submission, patient recruitment, and clinical trial management. They are known for compressing clinical timelines by up to 40% and reducing costs by 30% compared to traditional US or European pathways while maintaining FDA/EMA-ready data standards.